ArticleDiagnostic and prognostic research2025
Guide to evaluating performance of prediction models for recurrent clinical events.
Article in Diagnostic and prognostic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating discrimination of prediction models for recurrent clinical events.Diagnostic and prognostic research · 2026Article
- Clinical prediction models using machine learning in oncology: challenges and recommendations.BMJ oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMany chronic conditions, such as epilepsy and asthma, are typified by recurrent events-repeated acute deterioration events of a similar type. Statistical models for these conditions often focus on evaluating the time to the first event. They therefore do not make use of data available on all events. Statistical models for recurrent events exist, but it is not clear how best to evaluate their performance. We compare the relative performance of statistical models for analysing recurrent events for epilepsy and asthma.
methodsWe studied two clinical exemplars of common and infrequent events: asthma exacerbations using the Optimum Patient Clinical Research Database, and epileptic seizures using data from the Standard versus New Antiepileptic Drug Study. In both cases, count-based models (negative binomial and zero-inflated negative binomial) and variants on the Cox model (Andersen-Gill and Prentice, Williams and Peterson) were used to assess the risk of recurrence (of exacerbations or seizures respectively). Performance of models was evaluated via numerical (root mean square prediction error, mean absolute prediction error, and prediction bias) and graphical (calibration plots and Bland-Altman plots) approaches.
resultsThe performance of the prediction models for asthma and epilepsy recurrent events could be evaluated via the selected numerical and graphical measures. For both the asthma and epilepsy exemplars, the Prentice, Williams and Peterson model showed the closest agreement between predicted and observed outcomes.
conclusionInappropriate models can lead to incorrect conclusions which disadvantage patients. Therefore, prediction models for outcomes associated with chronic conditions should include all repeated events. Such models can be evaluated via the promoted numerical and graphical approaches alongside modified calibration measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.